1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Active TB
1.4.3 Latent TB
1.5 Market by Application
1.5.1 Global Tuberculosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Treatment Market Perspective (2015-2026)
2.2 Global Tuberculosis Treatment Growth Trends by Regions
2.2.1 Tuberculosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tuberculosis Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Treatment Revenue in 2019
3.3 Tuberculosis Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Treatment Market Size (2015-2020)
6.2 Tuberculosis Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tuberculosis Treatment Market Size (2015-2020)
7.2 Tuberculosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Tuberculosis Treatment Market Size (2015-2020)
8.2 Tuberculosis Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tuberculosis Treatment Market Size (2015-2020)
9.2 Tuberculosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tuberculosis Treatment Market Size (2015-2020)
10.2 Tuberculosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Tuberculosis Treatment Market Size (2015-2020)
11.2 Tuberculosis Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tuberculosis Treatment Market Size (2015-2020)
12.2 Tuberculosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Tuberculosis Treatment Introduction
13.1.4 Sanofi Revenue in Tuberculosis Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Tuberculosis Treatment Introduction
13.2.4 Bayer Revenue in Tuberculosis Treatment Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Tuberculosis Treatment Introduction
13.3.4 Eli Lilly Revenue in Tuberculosis Treatment Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Labatec Pharma
13.4.1 Labatec Pharma Company Details
13.4.2 Labatec Pharma Business Overview
13.4.3 Labatec Pharma Tuberculosis Treatment Introduction
13.4.4 Labatec Pharma Revenue in Tuberculosis Treatment Business (2015-2020)
13.4.5 Labatec Pharma Recent Development
13.5 Macleods Pharmaceuticals
13.5.1 Macleods Pharmaceuticals Company Details
13.5.2 Macleods Pharmaceuticals Business Overview
13.5.3 Macleods Pharmaceuticals Tuberculosis Treatment Introduction
13.5.4 Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2015-2020)
13.5.5 Macleods Pharmaceuticals Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview
13.6.3 Mylan Tuberculosis Treatment Introduction
13.6.4 Mylan Revenue in Tuberculosis Treatment Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Novatis
13.7.1 Novatis Company Details
13.7.2 Novatis Business Overview
13.7.3 Novatis Tuberculosis Treatment Introduction
13.7.4 Novatis Revenue in Tuberculosis Treatment Business (2015-2020)
13.7.5 Novatis Recent Development
13.8 Otsuka
13.8.1 Otsuka Company Details
13.8.2 Otsuka Business Overview
13.8.3 Otsuka Tuberculosis Treatment Introduction
13.8.4 Otsuka Revenue in Tuberculosis Treatment Business (2015-2020)
13.8.5 Otsuka Recent Development
13.9 Patheon
13.9.1 Patheon Company Details
13.9.2 Patheon Business Overview
13.9.3 Patheon Tuberculosis Treatment Introduction
13.9.4 Patheon Revenue in Tuberculosis Treatment Business (2015-2020)
13.9.5 Patheon Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Tuberculosis Treatment Introduction
13.10.4 Pfizer Revenue in Tuberculosis Treatment Business (2015-2020)
13.10.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Sanofi、Bayer、Eli Lilly、Labatec Pharma、Macleods Pharmaceuticals、Mylan、Novatis、Otsuka、Patheon、Pfizer
【免責事項】
https://www.globalresearch.jp/disclaimer